Jane Street’s MiMedx Group MDXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.05M | Buy |
792,311
+266,839
| +51% | +$974K | ﹤0.01% | 4481 |
|
|
2026
Q1 | $2.08M | Buy |
525,472
+266,210
| +103% | +$1.34M | ﹤0.01% | 5018 |
|
|
2025
Q4 | $1.76M | Sell |
259,262
-2
| -0% | -$14 | ﹤0.01% | 5056 |
|
|
2025
Q3 | $1.81M | Sell |
259,264
-47,249
| -15% | -$328K | ﹤0.01% | 5123 |
|
|
2025
Q2 | $1.87M | Buy |
306,513
+70,116
| +30% | +$466K | ﹤0.01% | 4535 |
|
|
2025
Q1 | $1.8M | Sell |
236,397
-149,197
| -39% | -$1.25M | ﹤0.01% | 4537 |
|
|
2024
Q4 | $3.71M | Buy |
385,594
+79,942
| +26% | +$623K | ﹤0.01% | 3095 |
|
|
2024
Q3 | $1.81M | Buy |
305,652
+174,797
| +134% | +$1.16M | ﹤0.01% | 4695 |
|
|
2024
Q2 | $907K | Buy |
130,855
+60,654
| +86% | +$426K | ﹤0.01% | 5948 |
|
|
2024
Q1 | $541K | Sell |
70,201
-3,737
| -5% | -$30K | ﹤0.01% | 6522 |
|
|
2023
Q4 | $648K | Buy |
+73,938
| New | +$541K | ﹤0.01% | 6322 |
|
|
2023
Q3 | – | Sell |
-71,368
| Closed | -$472K | – | 9083 |
|
|
2023
Q2 | $472K | Buy |
71,368
+12,059
| +20% | +$61.5K | ﹤0.01% | 6410 |
|
|
2023
Q1 | $202K | Sell |
59,309
-6,100
| -9% | -$23.6K | ﹤0.01% | 7830 |
|
|
2022
Q4 | $182K | Buy |
+65,409
| New | +$196K | ﹤0.01% | 7738 |
|
|
2022
Q2 | – | Sell |
-30,779
| Closed | -$145K | – | 10404 |
|
|
2022
Q1 | $145K | Buy |
30,779
+8,696
| +39% | +$42.5K | ﹤0.01% | 9259 |
|
|
2021
Q4 | $133K | Sell |
22,083
-62,628
| -74% | -$435K | ﹤0.01% | 9080 |
|
|
2021
Q3 | $513K | Sell |
84,711
-11,909
| -12% | -$134K | ﹤0.01% | 7239 |
|
|
2021
Q2 | $1.21M | Buy |
+96,620
| New | +$1.05M | ﹤0.01% | 5415 |
|
|
2018
Q4 | – | Sell |
-148,657
| Closed | -$919K | – | 5399 |
|
|
2018
Q3 | $919K | Buy |
+148,657
| New | +$672K | ﹤0.01% | 2860 |
|
|
2017
Q3 | – | Sell |
-10,784
| Closed | -$160K | – | 4824 |
|
|
2017
Q2 | $161K | Buy |
+10,784
| New | +$144K | ﹤0.01% | 4085 |
|
|
2016
Q2 | – | Sell |
-18,195
| Closed | -$159K | – | 4371 |
|
|
2016
Q1 | $159K | Buy |
18,195
+6,977
| +62% | +$58K | ﹤0.01% | 3782 |
|
|
2015
Q4 | $105K | Buy |
+11,218
| New | +$97.2K | ﹤0.01% | 3783 |
|
|
2014
Q3 | – | Sell |
-55,198
| Closed | -$391K | – | 2863 |
|
|
2014
Q2 | $391K | Buy |
55,198
+38,946
| +240% | +$228K | 0.01% | 1610 |
|
|
2014
Q1 | $100K | Buy |
+16,252
| New | +$119K | ﹤0.01% | 2519 |
|
|
2013
Q4 | – | Sell |
-32,667
| Closed | -$136K | – | 2681 |
|
|
2013
Q3 | $136K | Buy |
+32,667
| New | +$180K | ﹤0.01% | 2500 |
|
Other funds holding MDXG
EWM
TI
NCM
PCMI
Jane Street's MDXG Position: Q2 2026 in Review
Jane Street increased its MiMedx Group (MDXG) stake by 51% in Q2 2026, buying an estimated $974K and bringing the position to 792,311 shares worth $3.05M. The position accounts for ﹤0.01% of the portfolio, ranked #4481.
Jane Street first reported a position in MDXG in Q3 2013 and has held it in 25 quarters since. The position peaked at $3.71M in Q4 2024. 226 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.
- Jane Street held 792,311 shares of MiMedx Group worth $3.05M as of Q2 2026.
- Jane Street bought 266,839 MiMedx Group shares in Q2 2026, an estimated $974K.
- MiMedx Group made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #4481 holding.
- Jane Street first reported a position in MiMedx Group in Q3 2013 and has held it in 25 quarters since.
- Jane Street's MiMedx Group position peaked at $3.71M in Q4 2024.
- 226 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.